Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
K110137Substantially Equivalent

Abx Pentra Enzymatic Creatinine Cp, Abx Pentra Multical, Abx Pentra N Control, Abx Pentra P Control, and Abx Pentra Urin

Horiba Abx SAS, Montpellier, FR / Abbreviated, Substantially Equivalent

K110137 is the FDA 510(k) clearance record for ABX PENTRA ENZYMATIC CREATININE CP, ABX PENTRA MULTICAL, ABX PENTRA N CONTROL, ABX PENTRA P CONTROL, AND ABX PENTRA URIN, a class II device, cleared for HORIBA ABX SAS on under FDA product code JFY (Enzymatic Method, Creatinine). FDA records list 17 510(k) clearances for HORIBA ABX SAS, from to . As of , FDA records show 2 recalls naming K110137.

Clearance record

Decision date
Received
(204 days to decision)
Product code
JFY Enzymatic Method, Creatinine
Regulation
21 CFR 862.1225
Device class
Class II
Review panel
Clinical Chemistry
Applicant
Horiba Abx Sas Parc Euromedecine, Montpellier, FR
510(k) summary
Summary PDF
Third party review
No

Clearances, product code JFY

Trailing 12 months
1 clearance under product code JFY in the twelve months to October 2026, February 2026 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code JFY, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20261
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260